Wanbury Ltd.

NSE: WANBURY | BSE: 524212

₹261.45

up-down-arrow-6.50 (-2.43%)

As on 18-Jun-2026IST

Market cap

info icon

₹910 Cr

Revenue (TTM)

info icon

₹650 Cr

P/E Ratio

info icon

13.8

P/B Ratio

info icon

6.3

Div. Yield

info icon

0 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score2/10

Growth Score fund-quick-summary-circle

Growth Score6/10

Valuation Score fund-quick-summary-circle

Valuation Score6/10

Momentum Score fund-quick-summary-circle

Momentum Score7/10

Wanbury Share Price

Compare

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 259.00 High: 267.00

52 Week Range

Low: 161.50 High: 315.20

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹66 Cr

  • ROEROE information

    84.2 %

  • ROCEROCE information

    36 %

  • Industry P/EIndustry P/E information

    42.46

  • EV/EBITDAEV/EBITDA information

    10.4

  • Debt to EquityDebt to Equity information

    1

  • Book ValueBook Value information

    ₹41.3

  • EPSEPS information

    ₹20.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    34,939,398

10 Years Aggregate

CFO

₹300.59 Cr

EBITDA

₹184.98 Cr

Net Profit

₹207.43 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Wanbury
15.4 2.1 5.5 -12.2 66.8 21.0 20.2
BSE Healthcare
9.3 0.6 11.8 9.5 23.7 13.8 12.3
As on 18-Jun-2026
Company
2025
2024
2023
2022
2021
2020
2019
Wanbury
-23.5 127.0 157.2 -41.5 71.1 150.1 -9.3
BSE Small Cap
-6.6 29.0 47.5 -1.8 62.8 32.1 -6.8
BSE Healthcare
-3.3 43.1 37.0 -12.1 20.9 61.4 -3.5

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Wanbury
261.5 910.0 650.3 66.1 14.2 56.7 13.8 6.3
3,136.3 25,674.8 1,339.4 356.4 33.2 23.2 72.1 15.5
413.8 15,838.3 2,268.6 150.1 10.6 5.4 88.4 4.0
782.1 19,386.4 5,365.6 595.0 16.6 13.3 32.6 3.8
973.5 15,523.5 8,279.6 397.8 9.9 6.4 39 2.2
883.5 15,819.9 4,078.3 1,371.9 30.2 15.9 11.2 1.7
1,651.2 18,922.3 1,421.6 -73.8 1.8 -1.1 -- 3.2
160.2 21,328.2 8,869.1 -383.1 1.0 -4.2 -- 2.6
440.3 17,777.6 3,738.7 316.7 12.5 7.5 56.1 3.7
1,989.2 32,323.8 3,373.0 199.0 12.6 5.9 151.8 6.5

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About Wanbury

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for anti-infectives, pain and analgesics, respiratory, gastroenterology, gynecology,...  rheumatology, and central nervous system, as well as for vitamins, minerals, and nutrition. It also provides API products for antidiabetics, antihistamines, antitussives, analgesics, antidepressants, and anti-inflammatory medicines. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India. 

  • Incorporated

    1988

  • Chairman

    --

  • Managing Director

    --

  • Headquarters

    Navi Mumbai, Maharashtra

  • Website

    www.wanbury.com

Edit peer-selector-edit

Quarterly Updates

FAQs for Wanbury

The share price of Wanbury Ltd is ₹261.45 (NSE) and ₹260.45 (BSE) as of 18-Jun-2026 IST. Wanbury Ltd has given a return of 66.79% in the last 3 years.

The P/E ratio of Wanbury Ltd is 13.76 times as on 18-Jun-2026, a 68 discount to its peers’ median range of 42.46 times.
The P/B ratio of Wanbury Ltd is 6.30 times as on 18-Jun-2026, a 65 premium to its peers’ median range of 3.81 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
25.19
14.96
2024
8.54
22.63
2023
0.00
-3.53
2022
3.41
-11.25
2021
0.00
-1.33

The 52-week high and low of Wanbury Ltd are Rs 315.20 and Rs 161.50 as of 19-Jun-2026.

Wanbury Ltd has a market capitalisation of ₹ 910 Cr as on 18-Jun-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Wanbury Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.